Dr Reddy's Laboratories Faces Form 483 from USFDA
Dr Reddy's Laboratories Ltd's API facility in Bollaram, Hyderabad, received a Form 483 with seven observations after a USFDA inspection. The inspection took place from November 13-19, 2024, and the company plans to address the issues identified within the given timeline.
- Country:
- India
Dr Reddy's Laboratories Ltd has been issued a Form 483 with seven observations by the US health regulator following an inspection of its pharmaceutical manufacturing facility in Bollaram, Hyderabad.
The US Food & Drug Administration (USFDA) carried out the Good Manufacturing Practice (GMP) inspection from November 13 to 19, 2024. At the conclusion of the inspection, the USFDA presented the Form 483 outlining potential violations.
The company has committed to resolving the issues within the stipulated timeline set by the regulatory body.
(With inputs from agencies.)
- READ MORE ON:
- Dr Reddy's
- USFDA
- Form 483
- pharmaceutical
- inspection
- Bollaram
- Hyderabad
- GMP
- API
- regulatory
ALSO READ
Hyderabad Police Ensure Safe Holi with Strict Measures
Tragic Case of Financial Harassment: Arrests Made in Hyderabad Family Suicide
England Women's Hockey Team Arrives in Hyderabad for World Cup Qualifiers
NMDC, IIT-Hyderabad Forge Pact to Boost Mining Technology
Pipeline Standoff: Fico Accuses Zelenskiy of Blocking Inspections
Google News